http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0213761-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18b9cd55dba64a23d7291da0536f98e0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
filingDate 1986-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc6f2f755510864e00612507c7142250
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aab97285ff8fceb95934fbbbc279dbac
publicationDate 1987-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0213761-A2
titleOfInvention Stable sodium aspirin tablet compositions
abstract Compositions are provided for the preparation of stable sodium aspirin tablets. The compositions comprise dry, crystalline sodium aspirin, an anhydrous binder that is unreactive to sodium aspirin and a hydrogenated animal or vegetable oil lubricant but lack the traditional tablet disintegrant. Tablets produced from these compositions can be stored for prolonged periods of time yet disintegrate in water at a rate comparable to that of ordinary aspirin.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6635278-B1
priorityDate 1985-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S59193825-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3421735-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3413052-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3985792-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0024690-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395645
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450159460
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10176596
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23673598
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226822385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23666729
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451720952
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407364030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448897384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226822384
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224

Total number of triples: 54.